- Scientists have developed an innovative at-home test designed to predict an individual's risk of developing Alzheimer's disease.
- The novel method combines a simple finger-prick blood test, which can be posted to labs, with an online cognitive assessment, both conveniently conducted from home.
- This home-based screening aims to identify individuals experiencing early memory and cognitive issues, allowing those at highest risk to be prioritised for further diagnostic tests, treatment, and support.
- The finger-prick blood tests look for specific biomarkers, p-tau217 and GFAP, which have been linked to Alzheimer's disease and broader brain decline respectively.
- Experts believe this approach could revolutionise dementia diagnosis by offering a scalable and cost-effective way to screen people, though larger and more diverse studies are needed to confirm its effectiveness in everyday healthcare settings.
IN FULL
